4//SEC Filing
MOEBIUS HANS 4
Accession 0001209191-22-053869
CIK 0001620463other
Filed
Oct 16, 8:00 PM ET
Accepted
Oct 17, 6:06 PM ET
Size
7.0 KB
Accession
0001209191-22-053869
Insider Transaction Report
Form 4
MOEBIUS HANS
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2022-10-13$1.35/sh+7,881$10,639→ 60,836 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-10-13−7,881→ 7,882 totalExercise: $1.35Exp: 2029-08-14→ Common Stock (7,881 underlying)
Footnotes (1)
- [F1]One-fourth of the shares subject to the option vested on June 1, 2020 and one-fourth of the shares subject to the option vest on each year thereafter.
Documents
Issuer
Athira Pharma, Inc.
CIK 0001620463
Entity typeother
Related Parties
1- filerCIK 0001822494
Filing Metadata
- Form type
- 4
- Filed
- Oct 16, 8:00 PM ET
- Accepted
- Oct 17, 6:06 PM ET
- Size
- 7.0 KB